Predictive Oncology Inc.
POAI
$0.95
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.07M | -2.44M | -2.17M | -- | -3.18M |
| Total Depreciation and Amortization | 170.30K | 166.10K | 573.60K | -- | 155.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -547.50K | 387.00K | -14.00K | -- | 400.20K |
| Change in Net Operating Assets | -876.10K | 1.13M | -538.50K | -- | -592.20K |
| Cash from Operations | -3.32M | -756.30K | -2.15M | -- | -3.22M |
| Capital Expenditure | -- | -- | 0.00 | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 625.00K | 0.00 | -- | -6.50K |
| Cash from Investing | 0.00 | 625.00K | 0.00 | -- | -6.50K |
| Total Debt Issued | 264.00K | -- | 0.00 | -- | 275.10K |
| Total Debt Repaid | -- | -- | -195.80K | -- | -38.00K |
| Issuance of Common Stock | 586.00K | 2.58M | 0.00 | -- | 3.70M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -123.10K | -79.70K | 0.00 | -- | -573.80K |
| Cash from Financing | 726.90K | 2.50M | -195.80K | -- | 3.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.60M | 2.37M | -2.34M | -- | 134.50K |